Literature DB >> 20203264

A key role for ATF3 in regulating mast cell survival and mediator release.

Mark Gilchrist1, William R Henderson, Andrew Morotti, Carrie D Johnson, Alex Nachman, Frank Schmitz, Kelly D Smith, Alan Aderem.   

Abstract

Activating transcription factor 3 (ATF3) is a basic leucine zipper transcription factor that plays a regulatory role in inflammation, cell division, and apoptosis. Mast cells (MCs) initiate many inflammatory responses and have a central role in allergy and allergic diseases. We report here that ATF3 has a central role in MC development and function. Bone marrow-derived MC populations from ATF3-deficient mice are unresponsive to interleukin-3 (IL-3)-induced maturation signals, and this correlates with increased apoptosis, diminished activation of the Akt kinase, and decreased phosphorylation of the proapoptotic protein Bad. Furthermore, ATF3-null mice lacked MCs in the peritoneum and dermis, showing that the in vitro results are recapitulated in vivo. ATF3-null MCs also showed functional defects; high-affinity immunoglobulin E receptor-mediated degranulation was significantly inhibited, whereas IL-4 and IL-6 expression was enhanced. This dual role of ATF3 provides insight into the complex interplay between MC development and its subsequent physiologic role.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203264      PMCID: PMC2890168          DOI: 10.1182/blood-2009-03-213512

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  The Bcl-2 family: roles in cell survival and oncogenesis.

Authors:  Suzanne Cory; David C S Huang; Jerry M Adams
Journal:  Oncogene       Date:  2003-11-24       Impact factor: 9.867

2.  c-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells.

Authors:  Yu-Nee Lee; Jan Tuckerman; Hovav Nechushtan; Gunter Schutz; Ehud Razin; Peter Angel
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

3.  Optimization of the isolation and effective use of mRNA from rat mast cells.

Authors:  M Gilchrist; A J MacDonald; I Neverova; B Ritchie; A D Befus
Journal:  J Immunol Methods       Date:  1997-02-28       Impact factor: 2.303

4.  Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.

Authors:  Mark Gilchrist; Vesteinn Thorsson; Bin Li; Alistair G Rust; Martin Korb; Jared C Roach; Kathleen Kennedy; Tsonwin Hai; Hamid Bolouri; Alan Aderem
Journal:  Nature       Date:  2006-05-11       Impact factor: 49.962

Review 5.  The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis.

Authors:  T Hai; M G Hartman
Journal:  Gene       Date:  2001-07-25       Impact factor: 3.688

6.  IL-3-mediated TNF production is necessary for mast cell development.

Authors:  Harry V Wright; Daniel Bailey; Mohit Kashyap; Christopher L Kepley; Marina S Drutskaya; Sergei A Nedospasov; John J Ryan
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

7.  Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice.

Authors:  Taro Fukao; Taketo Yamada; Masanobu Tanabe; Yasuo Terauchi; Takayuki Ota; Tetsuro Takayama; Tomoichiro Asano; Tsutomu Takeuchi; Takashi Kadowaki; Jun-ichi Hata Ji; Shigeo Koyasu
Journal:  Nat Immunol       Date:  2002-02-19       Impact factor: 25.606

8.  De novo synthesis of early growth response factor-1 is required for the full responsiveness of mast cells to produce TNF and IL-13 by IgE and antigen stimulation.

Authors:  Bo Li; Melanie R Power; Tong-Jun Lin
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

9.  Essential role for the p110delta phosphoinositide 3-kinase in the allergic response.

Authors:  Khaled Ali; Antonio Bilancio; Matthew Thomas; Wayne Pearce; Alasdair M Gilfillan; Christine Tkaczyk; Nicolas Kuehn; Alexander Gray; June Giddings; Emma Peskett; Roy Fox; Ian Bruce; Christoph Walker; Carol Sawyer; Klaus Okkenhaug; Peter Finan; Bart Vanhaesebroeck
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

10.  Tetrahydrobiopterin, a critical factor in the production and role of nitric oxide in mast cells.

Authors:  Mark Gilchrist; Christian Hesslinger; A Dean Befus
Journal:  J Biol Chem       Date:  2003-09-26       Impact factor: 5.157

View more
  13 in total

1.  Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses.

Authors:  Daniel E Zak; Frank Schmitz; Elizabeth S Gold; Alan H Diercks; Jacques J Peschon; Joe S Valvo; Antti Niemistö; Irina Podolsky; Shannon G Fallen; Rosa Suen; Tetyana Stolyar; Carrie D Johnson; Kathleen A Kennedy; M Kristina Hamilton; Owen M Siggs; Bruce Beutler; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 2.  ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component?

Authors:  Tsonwin Hai; Christopher C Wolford; Yi-Seok Chang
Journal:  Gene Expr       Date:  2010

3.  Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Mihir Gupta; Kathryn Luk; Marna E Ericson; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

4.  ATF3 is a novel regulator of mouse neutrophil migration.

Authors:  Nicholas D Boespflug; Sachin Kumar; Jaclyn W McAlees; James D Phelan; H Leighton Grimes; Kasper Hoebe; Tsonwin Hai; Marie-Dominique Filippi; Christopher L Karp
Journal:  Blood       Date:  2014-01-27       Impact factor: 22.113

5.  Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.

Authors:  Heng Zhou; Di-Fei Shen; Zhou-Yan Bian; Jing Zong; Wei Deng; Yan Zhang; Yuan-Yuan Guo; Hongliang Li; Qi-Zhu Tang
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

6.  Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.

Authors:  Z Wang; D Xu; H-F Ding; J Kim; J Zhang; T Hai; C Yan
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

7.  TLR4 mediates pneumolysin-induced ATF3 expression through the JNK/p38 pathway in Streptococcus pneumoniae-infected RAW 264.7 cells.

Authors:  Cuong Thach Nguyen; Eun-Hye Kim; Truc Thanh Luong; Suhkneung Pyo; Dong-Kwon Rhee
Journal:  Mol Cells       Date:  2014-12-16       Impact factor: 5.034

Review 8.  The transcriptional program, functional heterogeneity, and clinical targeting of mast cells.

Authors:  Gökhan Cildir; Harshita Pant; Angel F Lopez; Vinay Tergaonkar
Journal:  J Exp Med       Date:  2017-08-15       Impact factor: 14.307

9.  Proteome and Secretome Analysis Reveals Differential Post-transcriptional Regulation of Toll-like Receptor Responses.

Authors:  Marijke Koppenol-Raab; Virginie Sjoelund; Nathan P Manes; Rachel A Gottschalk; Bhaskar Dutta; Zachary L Benet; Iain D C Fraser; Aleksandra Nita-Lazar
Journal:  Mol Cell Proteomics       Date:  2017-02-24       Impact factor: 5.911

10.  Subamolide a induces mitotic catastrophe accompanied by apoptosis in human lung cancer cells.

Authors:  Jen-Yu Hung; Ching-Wen Wen; Ya-Ling Hsu; En-Shyh Lin; Ming-Shyan Huang; Chung-Yi Chen; Po-Lin Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.